Anne Offermann

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer

Isabel Heidegger, Georgios Fotakis, Anne Offermann et al. · Molecular Cancer · 2022 · 182 citations · Full text

Medicine, Cell Biology, Oncology +17

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Marie C. Hupe, Christian Philippi, Doris Roth et al. · Frontiers in Oncology · 2018 · 179 citations · Full text

Medicine, Oncology, Urology +17

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer

Johannes Brägelmann, Niklas Klümper, Anne Offermann et al. · Clinical Cancer Research · 2016 · 113 citations

Medicine, Cancer Biology, Oncology +17

KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells

Eric Metzger, Sheng Wang, Sylvia Urban et al. · Nature Structural & Molecular Biology · 2019 · 109 citations

Life Sciences, Cancer Biology, Molecular Biology +12

Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion

Christian Watermann, Helen Pasternack, Christian Idel et al. · Clinical Cancer Research · 2020 · 77 citations · Full text

Medicine, Immunology, Oncology +17